Personnel Information

写真a

ISHIMARU NAOZUMI


Job title

Professor

Field Introduction URL

東京医科歯科大学口腔病理学分野HP

To the head of this page.▲

Graduating School 【 display / non-display 】

  • The University of Tokushima, Faculty of Dentistry, Graduated

To the head of this page.▲

Graduate School 【 display / non-display 】

  • The University of Tokushima, Graduate School, Division of Dental Research, Doctor's Course, Completed

To the head of this page.▲

Degree 【 display / non-display 】

  • DDS., PhD., The University of Tokushima

To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2024.05
    -
    2024.09
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Oral Health Sciences， Oral Pathology， Professor
  • 2024.10
    -
    Now
    Institute of Science Tokyo， -， Graduate Schools， Oral Health Sciences， Oral Pathology， Professor
To the head of this page.▲

External Career 【 display / non-display 】

  • 1998.04
    -
    1999.03
    , Dental Resident
  • 1999.04
    -
    2002.09
    , Assistant Professor
  • 2002.10
    -
    2003.03
    , Assistant Professor
  • 2003.04
    -
    2011.04
    , Associate Professor
  • 2003.08
    -
    2005.03
    SCRIPPS Research Institute, Department of Immunology,
  • 2009.12
    -
    2010.03
    Garvan Medical Institute,
  • 2011.05
    -
    2024.04
    , Professor
  • 2017.04
    -
    2021.03
    , Director
  • 2018.10
    -
    2024.04
    , Professor
  • 2024.05
    -
    Now
    Institute of Science Tokyo (Tokyo Medical and Dental University), Graduate School of Medical and Dental Sciences, Department of Oral Pathology, Professor

▼display all

To the head of this page.▲

Academic Society Affiliations 【 display / non-display 】

  • JAPANESE STOMATOLOGICAL SOCIETY

To the head of this page.▲

Academic Activity 【 display / non-display 】

  • 2022.07
    -
    Now
    Frontiers in Immunology Associate Editor
To the head of this page.▲

Research Areas 【 display / non-display 】

  • Immunology

  • Human pathology

  • Experimental pathology

  • Immunology

  • Surgical dentistry

  • Oral biological science

▼display all

To the head of this page.▲

Qualification Acquired 【 display / non-display 】

  • Dentist

To the head of this page.▲
 

Research Theme 【 display / non-display 】

  • Clinical application based on the molecular mechanism of autoantibody production in autoimmunity, 2023.06 - 2025.03

  • Novel pathogenesis and therapeutic strategy of autoimmunity based on immune-tuning molecules, 2023.04 - 2027.03

  • Common molecular mechanisms underlying age- and autoimmune-related disturbance of salivary secretion, 2021.04 - 2024.03

  • Establishment of novel oral cancer stem cell model mimicking human oral cancer by reprogramming and insertion of gene mutation, 2019.04 - 2022.03

  • Establishment of highly metastatic mice model of oral squamous cell carcinoma, 2017.06 - 2019.03

  • Study on the generation of oral cancer stem cell and analysis of its nature, 2017.06 - 2019.03

  • Development of a novel treatment method for xerostomia by dental pulp stem cell-derived humoral factor, 2017.04 - 2020.03

  • Clarification of the mechanism of oral carcinogenesis by the defect of degradation of chromosome passenger complex protein, 2016.04 - 2019.03

  • Analysis of autoimmunity caused by environmental factors~New pathogenesis of autoimmune disease~, 2016.04 - 2019.03

  • Elucidation of novel mechanism to lead DNA over-replication, 2016.04 - 2019.03

  • Analysis of molecular mechanisms of sensitization phase to develop effective treatments against metal allergy, 2015.04 - 2018.03

  • Analysis of migration factor expressed in dendritic cells during metal allergy development, 2015.04 - 2018.03

  • Explore for master regulator of EMT in oral cancer, 2015.04 - 2017.03

▼display all

To the head of this page.▲

Published Papers & Misc 【 display / non-display 】

  1. Involvement of metformin and aging in salivary expression of ACE2 and TMPRSS2. 2025; 51 (1): e2154. ( PubMed, DOI )

  2. Kazutaka Nakamura, Masayuki Tsukasaki, Takaaki Tsunematsu, Minglu Yan, Yutaro Ando, Nam Cong-Nhat Huynh, Kyoko Hashimoto, Qiao Gou, Ryunosuke Muro, Ayumi Itabashi, Takahiro Iguchi, Kazuo Okamoto, Takashi Nakamura, Kenta Nakano, Tadashi Okamura, Tomoya Ueno, Kosei Ito, Naozumi Ishimaru, Kazuto Hoshi, Hiroshi Takayanagi. The periosteum provides a stromal defence against cancer invasion into the bone. Nature. 2024.10; 634 (8033): 474-481. ( PubMed, DOI )

  3. Aota Keiko, Kani Koichi, Ono Shinji, Naniwa Kohei, Momota Yukihiro, Fukui Makoto, Ishimaru Naozumi, Azuma Masayuki. Activation of Janus kinase 2 contributes to the autoimmune pathology in the salivary glands of patients with Sjoegren's syndrome(タイトル和訳中) Oral Science International. 2024.09; 21 (3): 415-424. ( ichushi )

  4. Daishiro Kobayashi, Masaya Deda, Junya Hayashi, Kota Hidaka, Yutaka Kohmura, Takaaki Tsunematsu, Kohei Nishino, Harunori Yoshikawa, Kento Ohkawachi, Kiyomi Nigorikawa, Tetsuro Yoshimaru, Naozumi Ishimaru, Wataru Nomura, Toyomasa Katagiri, Hidetaka Kosako, Akira Otaka. Sulfoxide-Mediated Cys-Trp-Selective Bioconjugation that Enables Protein Labeling and Peptide Heterodimerization. Chem Eur. 2024.07; e202400014.

  5. Akiko Yamada, Akira Watanabe, Atsushi Nara, Naozumi Ishimaru, Kosuke Maeda, Yusuke Ido, Kazumasa Kotake, Masatake Asano, Yasuo Shinohara, Takenori Yamamoto. Longitudinal Analysis of Mitochondrial Function in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. Int J Mol Sci. 2024.06; 25 (11): ( PubMed, DOI )

  6. Aya Ushio, Mami Matsuda-Lennikov, Felix Kalle-Youngoue, Akihide Shimizu, Abdalla Abdelmaksoud, Michael C Kelly, Naozumi Ishimaru, Yousuke Takahama. Functionally diverse thymic medullary epithelial cells interplay to direct central tolerance. Cell Rep. 2024.04; 43 (4): 114072. ( PubMed, DOI )

  7. Hiroaki Tawara, Takaaki Tsunematsu, Shojiro Kitajima, Ruka Nagao, Shigefumi Matsuzawa, Kunihiro Otsuka, Aya Ushio, Naozumi Ishimaru. The noncanonical function of borealin, a component of chromosome passenger complex, promotes glycolysis via stabilization of survivin in squamous cell carcinoma cells. Biochem Biophys Res Commun. 2024.04; 706 149741. ( PubMed, DOI )

  8. Keiko Aota, Koichi Kani, Shinji Ono, Kohei Naniwa, Yukihiro Momota, Makoto Fukui, Naozumi Ishimaru, Masayuki Azuma. Activation of Janus kinase 2 contributes to the autoimmune pathology in the salivary glands of patients with Sjögren's syndrome Oral Science International . 2024.03; (21): 415-424. ( DOI )

  9. 多層カーボンナノチューブが免疫システムに及ぼす影響(The influence of multi-walled carbon nanotube for immune systems) 2024.02; 113 (1): 370. ( ichushi )

  10. がん特殊化リボソームの同定と機能解析(Identification and characterization of cancer-specialized ribosomes) 2024.02; 113 (1): 295. ( ichushi )

  11. シェーグレン症候群の病態形成に対するT細胞の共抑制性受容体の役割の解析(Analysis of the role of co-inhibitory receptors on T cells to the pathogenesis of Sjogren's syndrome) 2024.02; 113 (1): 297. ( ichushi )

  12. CRTC1::MAML2融合遺伝子の検出で確定診断に至った粘表皮癌の2例(Detection of the CRTC1::MAML2 fusion gene in two atypical cases of mucoepidermoid carcinoma) 2024.02; 113 (1): 346. ( ichushi )

  13. Borealin-Survivin複合体は頭頸部扁平上皮癌の分化を直接的に制御する(Borealin-Survivin complex directly regulates keratinocyte differentiation in HNSCC) 2024.02; 113 (1): 296. ( ichushi )

  14. Therapeutic Strategy Based on the Pathogenesis for Sjögren's Syndrome 2024; 37 (1): 1-5. ( DOI )

  15. Shimizu Motomu, Hojo Motoki, Ikushima Kiyomi, Yamamoto Yukio, Maeno Ai, Sakamoto Yoshimitsu, Ishimaru Naozumi, Taquahashi Yuhji, Kanno Jun, Hirose Akihiko, Suzuki Jin, Inomata Akiko, Nakae Dai. Continuous infiltration of small peritoneal macrophages in the mouse peritoneum through CCR2-dependent and -independent routes during fibrosis and mesothelioma development induced by a multiwalled carbon nanotube, MWNT-7(タイトル和訳中) The Journal of Toxicological Sciences. 2023.12; 48 (10-12): 617-639. ( ichushi )

  16. Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma. 2023.11; 12 (24): 22156-22169. ( PubMed, DOI )

  17. C-terminus of PIEZO1 governs Ca2+ influx and intracellular ERK1/2 signaling pathway in mechanotransduction 2023.11; 682 39-45. ( PubMed, DOI )

  18. 頭頸部扁平上皮癌(HNSCC)の進行における脱ユビキチン化酵素OTUB1の役割(The role of deubiquitinating enzyme, OTUB1 in head and neck squamous cell carcinoma(HNSCC) progression) 2023.09; 82回 1084. ( ichushi )

  19. CD4+ T-cell-dependent differentiation of CD23+ follicular B cells contributes to the pulmonary pathology in a primary Sjögren’s syndrome mouse model 2023.07; 14 1217492. ( PubMed, DOI )

  20. Iroquois homeobox 3 regulates odontoblast proliferation and differentiation mediated by Wnt5a expression. 2023.04; 650 47-54. ( PubMed, DOI )

  21. シェーグレン症候群疾患モデルマウスにおけるMucin19の異常と病態との関連性の解析(Relation between Disfunction of Mucin 19 and Pathogenesis in a Mouse Model of Sjogren's Syndrome) 2023.03; 112 (1): 377. ( ichushi )

  22. Cancer cell-derived novel periostin isoform promotes invasion in head and neck squamous cell carcinoma. 2023.01; 12 (7): 8510-8525. ( PubMed, DOI )

  23. Continuous infiltration of small peritoneal macrophages in the mouse peritoneum through CCR2-dependent and -independent routes during fibrosis and mesothelioma development induced by a multiwalled carbon nanotube, MWNT-7. 2023; 48 (12): 617-639. ( PubMed, DOI )

  24. Short-chain fatty acids profiling in biological samples from a mouse model of Sjögren's syndrome based on derivatized LC-MS/MS assay. 2022.11; 1210 123432. ( PubMed, DOI )

  25. Disturbed natural killer cell homeostasis in the salivary gland enhances autoimmune pathology via IFN-γ in a mouse model of primary Sjögren's syndrome. 2022.11; 9 1036787. ( PubMed, DOI )

  26. 脱ユビキチン化酵素OTUB1の頭頸部扁平上皮癌の進展における役割(The role of the deubiquitylating enzyme, OTUB1 in head and neck squamous cell carcinoma progression) 2022.09; 2022 165. ( ichushi )

  27. Exposure to Multi-Wall Carbon Nanotubes Promotes Fibrous Proliferation by Production of Matrix Metalloproteinase-12 via NF-κB Activation in Chronic Peritonitis. 2022.08; 192 (11): 1559-1572. ( PubMed, DOI )

  28. Virus Infections Play Crucial Roles in the Pathogenesis of Sjögren’s Syndrome 2022.07; 14 (7): 1474. ( PubMed, DOI )

  29. The Priming Potential of Interferon Lambda-1 for Antiviral Defense in the Oral Mucosa. 2022.06; 45 (3): 1348-1361. ( PubMed, DOI )

  30. Reversal of neuroinflammation in novel GS model mice by single i.c.v. administration of CHO-derived rhCTSA precursor protein. 2022.06; 25 297-310. ( PubMed, DOI )

  31. Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity. 2022.05; 55 (5): 912-924. ( PubMed, DOI )

  32. PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity. 2022.03; 23 (3): 399-410. ( PubMed, DOI )

  33. von Willebrand factor D and EGF domains regulate ameloblast differentiation and enamel formation 2021.12; 237 (3): 1964-1979. ( PubMed, DOI )

  34. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells 2021.12; 11 (1): 14943. ( PubMed, DOI )

  35. Protective effects of resveratrol against 5-fluorouracil-induced oxidative stress and inflammatory responses in human keratinocytes. 2021.11; 69 (3): 238-246. ( PubMed, DOI )

  36. Chen Shu, Tamaki Naofumi, Kudo Yasusei, Tsunematsu Takaaki, Miki Kaname, Ishimaru Naozumi, Ito Hiro-o. ヒト角化細胞における5-フルオロウラシル誘発性酸化ストレスおよび炎症反応に対するレスベラトロールの防御効果(Protective effects of resveratrol against 5-fluorouracil-induced oxidative stress and inflammatory responses in human keratinocytes) Journal of Clinical Biochemistry and Nutrition. 2021.11; 69 (3): 238-246. ( ichushi )

  37. The thymoproteasome hardwires the TCR repertoire of CD8+ T cells in the cortex independent of negative selection. 2021.04; 218 (4): ( PubMed, DOI )

  38. The life in Japan and status of private dental office at the times of COVID-19. 2021.04; 27 Suppl 3 (Suppl 3): 727-729. ( PubMed, DOI )

  39. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice. 2021.02; 22 (5): ( PubMed, DOI )

  40. 頭頸部扁平上皮癌の予後を予測する新規システムの構築 2020.10; 79回 PJ14-2. ( ichushi )

  41. Sento Shinya, Kudo Yasusei, Hibiya Kenji, Ishimaru Naozumi, Sasabe Eri, Kitamura Naoya, Yamamoto Tetsuya. 舌前方の唾液腺の硝子化明細胞癌　1症例報告と文献レビュー(Hyalinizing clear cell carcinoma of the anterior lingual salivary gland: A case report and review of the literature) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2020.07; 32 (4): 267-274. ( ichushi )

  42. Prognostic value of partial-EMT-related genes in head and neck squamous cell carcinoma by a bioinformatic analysis. 2020.04; ( PubMed, DOI )

  43. Otsuka K, Yamada A, Saito M, Ushio A, Sato M, Kisoda S, Shao W, Tsunematsu T, Kudo Y, Arakaki R, Ishimaru N. Achaete-Scute Homologue 2-Regulated Follicular Helper T Cells Promote Autoimmunity in a Murine Model for Sjögren Syndrome. The American journal of pathology. 2019.12; 189 (12): 2414-2427. ( PubMed, DOI )

  44. A novel method for measuring small amounts of saliva in mice 2019.12; 16 (3): 178-180. ( DOI )

  45. Arakaki Rieko, Ushio Aya, Otsuka Kunihiro, Kudo Yasusei, Ishimaru Naozumi. マウスにおける少量の唾液を計測する新規方法(A novel method for measuring small amounts of saliva in mice) Oral Science International. 2019.12; 16 (3): 178-180. ( ichushi )

  46. Yuyama K, Nakamura Y, Tateyama R, Arakaki R, Tsutsui T, Ishimaru N. Study of the pharmacokinetics of eriodictyol-6-C-β-d-glucoside, a flavonoid of rooibos (Aspalathus linearis) extract, after its oral administration in mice. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2019.11; 1137 121881. ( PubMed, DOI )

  47. Shikama Y, Kurosawa M, Furukawa M, Ishimaru N, Matsushita K. Involvement of adiponectin in age-related increases in tear production in mice. Aging. 2019.10; 11 (19): 8329-8346. ( PubMed, DOI )

  48. 口腔癌におけるpartial EMTに関連する遺伝子の悪性度への関与(Involvement of partial EMT gene in malignant behavior of head and neck squamous cell carcinoma) 2019.09; 78回 J-1011. ( ichushi )

  49. Arakaki R, Ushio A, Kisoda S, Sato M, Nakamura Y, Yuyama K, Tateyama R, Morishita S, Monoi N, Kudo Y, Ishimaru N. Novel effects of rooibos extract on tear and saliva secretion mediated by the muscarinic acetylcholine receptor 3 in mice. Journal of oral biosciences. 2019.09; 61 (3): 179-182. ( PubMed, DOI )

  50. Arakaki Rieko, Ushio Aya, Kisoda Satoru, Sato Mami, Nakamura Yoshitaka, Yuyama Kanako, Tateyama Riho, Morishita Satoru, Monoi Noriyuki, Kudo Yasusei, Ishimaru Naozumi. マウスにおいて3型ムスカリン性アセチルコリン受容体を介した涙液分泌および唾液分泌に対するルイボス抽出物の新規作用(Novel effects of rooibos extract on tear and saliva secretion mediated by the muscarinic acetylcholine receptor 3 in mice) Journal of Oral Biosciences. 2019.09; 61 (3): 179-182. ( ichushi )

  51. Nakatomi C, Nakatomi M, Matsubara T, Komori T, Doi-Inoue T, Ishimaru N, Weih F, Iwamoto T, Matsuda M, Kokabu S, Jimi E. Constitutive activation of the alternative NF-κB pathway disturbs endochondral ossification. Bone. 2019.04; 121 29-41. ( PubMed, DOI )

  52. Otsuka Kunihiro, Yamada Akiko, Saito Masako, Ushio Aya, Tsunematsu Takaaki, Kisoda Satoru, Kudo Yasusei, Arakaki Rieko, Ishimaru Naozumi. 組織特異的免疫疾患 シェーグレン症候群マウスモデルの自己免疫における濾胞性ヘルパーT細胞の重要な役割(Tissue-specific immune diseases-2 A crucial role of follicular helper T cells in autoimmunity of a mouse model for Sjoegren's syndrome) 日本免疫学会総会・学術集会記録. 2018.12; 47 (Proceedings): 3-B. ( ichushi )

  53. Ushio Aya, Arakaki Rieko, Otsuka Kunihiro, Yamada Akiko, Kudo Yasusei, Ishimaru Naozumi. 組織特異的免疫疾患 CCL22産生マクロファージはシェーグレン症候群の標的器官においてT細胞自己免疫を促進する(Tissue-specific immune diseases-2 CCL22-producing macrophages promote T cell autoimmunity in the target organ of Sjoegren's syndrome) 日本免疫学会総会・学術集会記録. 2018.12; 47 (Proceedings): 3-B. ( ichushi )

  54. Aota K, Yamanoi T, Kani K, Nakashiro KI, Ishimaru N, Azuma M. Inverse correlation between the number of CXCR3<sup>+</sup> macrophages and the severity of inflammatory lesions in Sjögren's syndrome salivary glands: A pilot study. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2018.08; 47 (7): 710-718. ( PubMed, DOI )

  55. Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma-A Review. 2018.05; 19 (5): ( PubMed, DOI )

  56. Distinct Regulation of CXCL10 Production by Cytokines in Human Salivary Gland Ductal and Acinar Cells 2018.03; 41 (4): 1-10. ( PubMed, DOI )

  57. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells. 2018.01; 17 (1): 10. ( PubMed, DOI )

  58. Long-term polarization of alveolar macrophages to a profibrotic phenotype after inhalation exposure to multi-wall carbon nanotubes. 2018; 13 (10): e0205702. ( PubMed, DOI )

  59. Ushio A, Arakaki R, Otsuka K, Yamada A, Tsunematsu T, Kudo Y, Aota K, Azuma M, Ishimaru N. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome. Frontiers in immunology. 2018; 9 2594. ( PubMed, DOI )

  60. Contributions of CXCL12 and its receptor to the T cell autoimmune response in a Sjogren's syndrome murine model 2018; 36 (3): S299-S300.

  61. Aurora Kinase Inhibitors in Head and Neck Cancer. 2018; 18 (3): 199-213. ( PubMed, DOI )

  62. 井澤 俊, 新垣 理恵子, 田中 栄二, 石丸 直澄. 核内受容体AhRはRANK/c-Fosシグナル伝達経路を介して破骨細胞の分化を制御する 生命科学系学会合同年次大会. 2017.12; 2017年度 [2P-0943]. ( ichushi )

  63. 大東 いずみ, 石丸 直澄, 片貝 智哉, 高浜 洋介. T細胞の自己寛容性確立におけるCCL21の役割 生命科学系学会合同年次大会. 2017.12; 2017年度 [4P2T24-06(3P. ( ichushi )

  64. The nuclear receptor AhR controls bone homeostasis by regulating osteoclast differentiation via the RANK/c-Fos signaling axis 2017.12; 32 S346.

  65. Kurosawa M, Arakaki R, Yamada A, Tsunematsu T, Kudo Y, Sprent J, Ishimaru N. NF-κB2 Controls the Migratory Activity of Memory T Cells by Regulating Expression of CXCR4 in a Mouse Model of Sjögren's Syndrome. Arthritis & rheumatology (Hoboken, N.J.). 2017.11; 69 (11): 2193-2202. ( PubMed, DOI )

  66. Preventive effects of mouthguard use while sleeping on recurrent aphthous stomatitis: Preliminary interventional study. 2017.10; 3 (5): 198-203. ( PubMed, DOI )

  67. Izawa T, author, Corresponding author, Arakaki R, Ishimaru N. Role of Fas and RANKL signaling in peripheral immune tolerance Journal of Clinical & Cellular Immunology. 2017.07; 8 (4): 512. ( DOI )

  68. Mina Kozai, Yuki Kubo, Tomoya Katakai, Hiroyuki Kondo, Hiroshi Kiyonari, Karin Schaeuble, Sanjiv A. Luther, Naozumi Ishimaru, Izumi Ohigashi, Yousuke Takahama. Essential role of CCL21 in establishment of central self-tolerance in T cells The Journal of Experimental Medicine. 2017.07; Vol.214 (No.7): 1925-1935. ( PubMed, DOI )

  69. Ushio A, Arakaki R, Eguchi H, Hotta F, Yamada A, Kudo Y, Ishimaru N. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome. International journal of molecular sciences. 2017.06; 18 (6): ( PubMed, DOI )

  70. Establishment and characterization of a clear cell odontogenic carcinoma cell line with EWSR1-ATF1 fusion gene 2017.06; 69 46-55. ( PubMed, DOI )

  71. Yamada Koichi, Arakaki Rieko, Yamada Akiko, Kudo Yasusei, Ishimaru Naozumi. 妊娠中のマウスにおける胸腺組織の遺伝子的変化および表現型上の変化(Genetic and Phenotypic Changes of Thymus Tissue in Mice during Pregnancy) Journal of Oral Health and Biosciences. 2017.06; 30 (1): 26-32. ( ichushi )

  72. Izawa T, author, Corresponding author, Arakaki R, Ishimaru N. Crosstalk between cytokine RANKL and AhR signalling in osteoclasts controls bone homeostasis Journal of Cytokine Biology. 2017.05; 2 (2): 114. ( DOI )

  73. Shikama Y, Kudo Y, Ishimaru N, Funaki M. Potential Role of Free Fatty Acids in the Pathogenesis of Periodontitis and Primary Sjögren's Syndrome. International journal of molecular sciences. 2017.04; 18 (4): ( PubMed, DOI )

  74. Dual role of Fas/FasL-mediated signal in peripheral immune tolerance 2017.04; 8 403. ( PubMed, DOI )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. 牛尾 綾, 松田 真実, 石丸 直澄, 高濱 洋介. 機能的に異なる胸腺髄質上皮細胞欠損マウスにおける自己免疫病変の病理組織学的検討(Pathological analysis of autoimmune phenotype in mice lacking functionally distinct thymic medullary epithelial cells). 日本病理学会会誌 2024.10.01

  2. 布川 裕規, 山本 浩平, 倉田 盛人, 清水 六花, 西井 直人, 黒嶋 雄志, 道 泰之, 原田 浩之, 石丸 直澄. 小唾液腺に発生したアミロイド沈着を伴ったLow-grade B-cell lymphomaの3例(Three cases of low-grade B-cell lymphoma with amyloid deposition involving the minor salivary glands). 日本病理学会会誌 2024.10.01

  3. 牛尾 綾, 大塚 邦紘, 常松 貴明, 高橋 祐次, 菅野 純, 石丸 直澄. 多層カーボンナノチューブが免疫システムに及ぼす影響(The influence of multi-walled carbon nanotube for immune systems). 日本病理学会会誌 2024.02.01

  4. 常松 貴明, 吉川 治孝, 永尾 瑠佳, 松澤 鎮史, 大塚 邦紘, 牛尾 綾, 石丸 直澄. がん特殊化リボソームの同定と機能解析(Identification and characterization of cancer-specialized ribosomes). 日本病理学会会誌 2024.02.01

  5. 永尾 瑠佳, 山本 安希子, 牛尾 綾, 大塚 邦紘, 松澤 鎮史, 常松 貴明, 石丸 直澄. シェーグレン症候群の病態形成に対するT細胞の共抑制性受容体の役割の解析(Analysis of the role of co-inhibitory receptors on T cells to the pathogenesis of Sjogren's syndrome). 日本病理学会会誌 2024.02.01

  6. 富田 満, 堀口 英久, 小川 博久, 上原 久典, 坂東 良美, 常松 貴明, 佐藤 真美, 石丸 直澄, 常山 幸一. CRTC1::MAML2融合遺伝子の検出で確定診断に至った粘表皮癌の2例(Detection of the CRTC1::MAML2 fusion gene in two atypical cases of mucoepidermoid carcinoma). 日本病理学会会誌 2024.02.01

  7. 俵 宏彰, 常松 貴明, 永尾 瑠佳, 松澤 鎮史, 大塚 邦紘, 牛尾 綾, 石丸 直澄. Borealin-Survivin複合体は頭頸部扁平上皮癌の分化を直接的に制御する(Borealin-Survivin complex directly regulates keratinocyte differentiation in HNSCC). 日本病理学会会誌 2024.02.01

  8. Tsunematsu Takaaki, Nagao Ruka, Matsuzawa Shigefumi, Otsuka Kunihiro, Ushio Aya, Ishimaru Naozumi. "Cancer cell cannibalism"の分子機序とがん進展における意義(The molecular mechanism of "Cancer cell cannibalism" and its significance in cancer progression). 日本免疫学会総会・学術集会記録 2023.12.01

  9. Kawahito Yuki, Tamura Kai, Sato Mami, Otsuka Kunihiro, Ushio Aya, Tsunematsu Takaaki, Ishimaru Naozumi. マウスにおけるムチン19の減少とシェーグレン症候群発症との関係(The Relation between the Reduction of Mucin 19 and the Onset of Sjoegren's Syndrome in a Mouse Model). 日本免疫学会総会・学術集会記録 2023.12.01

  10. Tamura Kai, Kawahito Yuki, Sato Mami, Otsuka Kunihiro, Ushio Aya, Tsunematsu Takaaki, Ishimaru Naozumi. シェーグレン症候群モデルマウスにおける加齢に伴う鼻病変の病理学的解析(Pathological analysis of nasal lesions with aging in murine models of Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2023.12.01

  11. Nagao Ruka, Yamamoto Akiko, Ushio Aya, Otsuka Kunihiro, Tawara Hiroaki, Matsuzawa Shigefumi, Tamura Kai, Kawahito Yuhki, Tsunematsu Takaaki, Ishimaru Naozumi. シェーグレン症候群における共抑制性受容体を介した活性化T細胞の抑制機構の解析(Analysis of the suppression mechanism for activated T cells via co-inhibitory receptors in Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2023.12.01

  12. Otsuka Kunihiro, Kondo Hiroyuki, Tsukumo Shi-ichi, Ushio Aya, Ishimaru Naozumi, Yasutomo Koji. CD153+CD4+T細胞とCD30+細胞がシェーグレン症候群の唾液腺における自己免疫病態を増悪させる(CD153+ CD4+ T cells and CD30+ cells exacerbate the autoimmune pathology in salivary glands of Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2023.12.01

  13. Matsuzawa Shigefumi, Ushio Aya, Nagao Ruka, Otsuka Kunihiro, Tawara Hiroaki, Tsunematsu Takaaki, Ishimaru Naozumi. 胸腺におけるT細胞の分化・成熟とオートファジーの関係に関する研究(Investigation of the relationship between T cell differentiation and maturation and autophagy in the thymus). 日本免疫学会総会・学術集会記録 2023.12.01

  14. 金 晟劍, 常松 貴明, 堀口 大吾, 毛利 安宏, 邵 文華, 三好 圭子, 水澤 典子, 萩田 浩子, 猿棒 元陽, 吉田 佳世, 吉田 賀弥, 藤原 奈津美, 尾崎 和美, 石丸 直澄, 工藤 保誠. 頭頸部扁平上皮癌(HNSCC)の進行における脱ユビキチン化酵素OTUB1の役割(The role of deubiquitinating enzyme, OTUB1 in head and neck squamous cell carcinoma(HNSCC) progression). 日本癌学会総会記事 2023.09.01

  15. 川人 祐樹, 田村 海, 佐藤 真美, 大塚 邦紘, 牛尾 綾, 常松 貴明, 石丸 直澄. シェーグレン症候群疾患モデルマウスにおけるMucin19の異常と病態との関連性の解析(Relation between Disfunction of Mucin 19 and Pathogenesis in a Mouse Model of Sjogren's Syndrome). 日本病理学会会誌 2023.03.01

  16. Sugiura Daisuke, Okazaki Il-mi, Maruhashi Takumi, Shimizu Kenji, Ishimaru Naozumi, Okazaki Taku. 免疫学的寛容と免疫抑制-2　抗CD80によるPD-1アゴニズムはT細胞の活性化を抑制し自己免疫を緩和させる(Tolerance and Immune suppression-2　PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity). 日本免疫学会総会・学術集会記録 2022.11.01

  17. Tsunematsu Takaaki, Arakaki Rieko, Sato Mami, Otsuka Kunihiro, Ishimaru Naozumi. 樹状細胞とマクロファージ-1　免疫制御とdisease perspectives　慢性腹膜炎における多層カーボンナノチューブ曝露によるNF-κB活性化を介したMatrix Metalloproteiase-12の産生による線維増殖の促進(Dendritic cells and macrophages-1:Immune regulation and disease perspectives　Exposure to Multi-Wall Carbon Nanotubes Promotes Fibrous Proliferation by Production of Matrix Metalloproteiase-12 via NF-κB Activation in Chronic Peritonitis). 日本免疫学会総会・学術集会記録 2022.11.01

  18. Kawahito Yuki, Tamura Kai, Sato Mami, Otsuka Kunihiro, Tsunematsu Takaaki, Ishimaru Naozumi. 自己免疫性疾患　全身性　シェーグレン症候群モデルマウスの病態形成におけるムチン19の役割(Autoimmune diseases-Systemic-　Role of Mucin 19 in Pathogenesis of a Mouse Model for Sjoegren's Syndrome). 日本免疫学会総会・学術集会記録 2022.11.01

  19. Tamura Kai, Kawahito Yuki, Sato Mami, Otsuka Kunihiro, Tsunematsu Takaaki, Ishimaru Naozumi. 自己免疫性疾患　全身性　シェーグレン症候群モデルマウスにおける鼻腔組織の病理学的解析(Autoimmune diseases-Systemic-　Pathological analysis of nasal tissue in a murine model of Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2022.11.01

  20. Otsuka Kunihiro, Kondo Hiroyuki, Tsukumo Shin-ichi, Arakaki Rieko, Sato Mami, Yagita Hideo, Ishimaru Naozumi, Yasutomo Koji. 自己免疫性疾患　全身性　CD153+CD4+T細胞はシェーグレン症候群の唾液腺におけるCD30+細胞との相互作用を介して自己免疫病態を増悪させる(Autoimmune diseases-Systemic-　CD153+ CD4+ T cells exacerbate the autoimmune pathology via the interaction with CD30+ cells in salivary glands in Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2022.11.01

  21. Sato Mami, Ushio Aya, Otsuka Kunihiro, Tsunematsu Takaaki, Ishimaru Naozumi. 自己免疫　シェーグレン症候群モデルマウスにおいてTh2応答は濾胞性B細胞への分化を促進し肺の自己免疫病変を進行させる(Autoimmunity　Th2 response enhances the differentiation into follicular B cells to progress the pulmonary autoimmune lesions in a mouse model of Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2022.11.01

  22. Jin Shengjian, 常松 貴明, 堀口 大吾, 石丸 直澄, 工藤 保誠. 脱ユビキチン化酵素OTUB1の頭頸部扁平上皮癌の進展における役割(The role of the deubiquitylating enzyme, OTUB1 in head and neck squamous cell carcinoma progression). Journal of Oral Biosciences Supplement 2022.09.01

  23. Sugiura Daisuke, Okazaki Il-mi, Maruhashi Takumi, Shimizu Kenji, Arakaki Reiko, Ishimaru Naozumi, Okazaki Taku. cis-PD-L1/CD80二量体の解離によるPD-1誘導はT細胞の活性化を抑制し自己免疫疾患を軽減する(PD-1 elicitation by the dissociation of cis-PD-L1/CD80 duplex inhibits T cell activation and alleviates autoimmunity). 日本免疫学会総会・学術集会記録 2021.11.01

  24. Arakaki Rieko, Tsunematsu Takaaki, Taquahashi Yuhji, Kanno Jun, Ishimaru Naozumi. ナノマテリアル吸入曝露による肺免疫応答と線維化の分子機構(Pulmonary Immune Response and Molecular Mechanism of Fibrosis by Inhalation Exposure to Nanomaterials). 日本免疫学会総会・学術集会記録 2021.11.01

  25. Otsuka Kunihiro, Tsukumo Shin-ishi, Arakaki Rieko, Yagita Hideo, Ishimaru Naozumi, Yasutomo Koji. シングルセルRNAシーケンシングにより明らかとなったシェーグレン症候群モデルマウスの唾液腺における特異的表現型を持つCD4およびCD8 T細胞の集積(Single-cell RNA sequencing reveals accumulation of CD4 and CD8 T cells with unique phenotypes in salivary glands of Sjoegren's syndrome model mice). 日本免疫学会総会・学術集会記録 2021.11.01

  26. Arakaki Rieko, Tsunematsu Takaaki, Ishimaru Naozumi. マウスへのルイボス抽出物口腔投与によるM3ムスカリン性アセチルコリン受容体を介した全身の乾燥の改善(Improvement of systemic dryness by oral administration of rooibos extract in mice via the M3 muscarinic acetylcholine receptor). 日本口腔ケア学会雑誌 2021.04.01

  27. 木曽田 暁, 邵 文華, 金 晟劍, 常松 貴明, 石丸 直澄, 工藤 保誠. 頭頸部扁平上皮癌の予後を予測する新規システムの構築. 日本癌学会総会記事 2020.10.01

  28. Shao Wenhua, Umeda Masaaki, Tsunematsu Takaaki, Kisoda Satoru, Ishimaru Naozumi, Kudo Yasusei. 頭頸部扁平上皮癌において新規のperiostin isoformは浸潤と転移を促進する(Novel periostin isoform promotes invasion and metastasis in head and neck squamous cell carcinoma). 日本病理学会会誌 2020.03.01

  29. Ushio Aya, Arakaki Rieko, Yamada Akiko, Kudo Yasusei, Ishimaru Naozumi. 樹状細胞、マクロファージ、顆粒球　個体発生と疾患の観点から　シェーグレン症候群のモデルマウスにおける肺病変の分析(Dendritic cells, macrophages, granulocytes: Ontogeny and disease perspectives　Analysis of pulmonary lesions in a murine model of Sjogren's syndrome). 日本免疫学会総会・学術集会記録 2019.11.01

  30. Arakaki Rieko, Sato Mami, Nakayama Shinichiro, Ushio Aya, Kudo Yasusei, Ishimaru Naozumi. 関節リウマチ、シェーグレン症候群、その他の自己免疫疾患　シェーグレン症候群の病状形成におけるIL-33とその受容体の役割(Rheumatoid arthritis, Sjogren's syndrome and other autoimmune diseases　Role of IL-33 and its receptor in pathogenesis of Sjogren's syndrome). 日本免疫学会総会・学術集会記録 2019.11.01

  31. Sato Mami, Arakaki Rieko, Ushio Aya, Kudo Yasusei, Ishimaru Naozumi. 樹状細胞、マクロファージ、顆粒球　免疫調節　多壁炭素ナノチューブへの曝露が肺免疫細胞に対して早期に及ぼす影響(Dendritic cells, macrophages, granulocytes: Immune regulation　Effect of multi-wall carbon nanotube exposure on pulmonary immune cells at the early stage). 日本免疫学会総会・学術集会記録 2019.11.01

  32. 木曽田 暁, 邵 文華, 常松 貴明, 石丸 直澄, 工藤 保誠. 口腔癌におけるpartial EMTに関連する遺伝子の悪性度への関与(Involvement of partial EMT gene in malignant behavior of head and neck squamous cell carcinoma). 日本癌学会総会記事 2019.09.01

  33. Ushio Aya, Arakaki Rieko, Otsuka Kunihiro, Yamada Akiko, Kudo Yasusei, Ishimaru Naozumi. 組織特異的免疫疾患　CCL22産生マクロファージはシェーグレン症候群の標的器官においてT細胞自己免疫を促進する(Tissue-specific immune diseases-2　CCL22-producing macrophages promote T cell autoimmunity in the target organ of Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2018.12.01

  34. Otsuka Kunihiro, Yamada Akiko, Saito Masako, Ushio Aya, Tsunematsu Takaaki, Kisoda Satoru, Kudo Yasusei, Arakaki Rieko, Ishimaru Naozumi. 組織特異的免疫疾患　シェーグレン症候群マウスモデルの自己免疫における濾胞性ヘルパーT細胞の重要な役割(Tissue-specific immune diseases-2　A crucial role of follicular helper T cells in autoimmunity of a mouse model for Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2018.12.01

  35. Arakaki Rieko, Nakayama Shinichiro, Ushio Aya, Otsuka Kunihiro, Kisoda Satoshi, Tsunematsu Takaaki, Yamada Akiko, Kudo Yasusei, Ishimaru Naozumi. 組織特異的免疫疾患　シェーグレン症候群(SS)の病因における切断型IL-33の役割(Tissue-specific immune diseases-2　The role of the cleaved form IL-33 in pathogenesis of Sjoegren's syndrome(SS)). 日本免疫学会総会・学術集会記録 2018.12.01

  36. 大東 いずみ, 石丸 直澄, 片貝 智哉, 高浜 洋介. T細胞の自己寛容性確立におけるCCL21の役割. 生命科学系学会合同年次大会 2017.12.01

  37. Izawa Takashi, Arakaki Rieko, Tanaka Eiji, Ishimaru Naozumi. サイトカインとケモカイン(2)　破骨細胞におけるサイトカインRANKLとAhRシグナル伝達のクロストークは骨ホメオスタシスを制御する(Cytokines and chemokines(2)　Crosstalk between cytokine RANKL and AhR signaling in osteoclasts controls bone homeostasis). 日本免疫学会総会・学術集会記録 2017.12.01

  38. 井澤 俊, 新垣 理恵子, 田中 栄二, 石丸 直澄. 核内受容体AhRはRANK/c-Fosシグナル伝達経路を介して破骨細胞の分化を制御する. 生命科学系学会合同年次大会 2017.12.01

  39. Otsuka Kunihiro, Yamada Akiko, Kurosawa Mie, Ushio Aya, Arakaki Rieko, Kudo Yasusei, Ishimaru Naozumi. 組織特異的免疫疾患(II)　シェーグレン症候群のマウスモデルにおける濾胞性ヘルパーT細胞の解析(Tissue-specific immune diseases(II)　Analysis of follicular helper T cells in a mouse model for Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2017.12.01

  40. Ushio Aya, Arakaki Rieko, Yamada Akiko, Otsuka Kunihiro, Kudo Yasusei, Ishimaru Naozumi. 樹状細胞とマクロファージ(3)　炎症反応　シェーグレン症候群のマウスモデルにおいてCCL22産生常在マクロファージは自己免疫病変を亢進させる(Dendritic cells and Macrophages: Inflammatory Responses　CCL22-producing resident macrophages enhances autoimmune lesions in a mouse model of Sjoegren's syndrome). 日本免疫学会総会・学術集会記録 2017.12.01

▼display all

To the head of this page.▲